BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Image Results

Loading...
Loading...

Rasburicase Fda Test G6PD Pages on BioPortfolio:

Results from other life science and pharmaceutical sites:

Rasburicase (Elitek)
PRECAUTIONS, Laboratory Test Interactions). DESCRIPTION. ELITEK (rasburicase) is a recombinant urate-oxidase enzyme produced by a genetically modified ...
http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProces...

Rasburicase: Drug Information Provided by Lexi-Comp: Merck Manual ...
The FDA-approved labeling includes a boxed warning. ... Use is contraindicated in patients with G6PD deficiency. ... Test Interactions. Specific handling
procedures must be followed to prevent the degradation of uric acid in plasma
...
http://www.merck.com/mmpe/lexicomp/rasburicase.html...

FDA Releases List of Genomic Biomarkers Predictive of Drug ...
1 Aug 2008 ... In contrast, testing may be recommended to avoid the risk of excessive drug ... Two drugs in this category are warfarin and rasburicase. ... G6PD deficiency is
more common in patients with Mediterranean or African ...
http://www.medscape.com/viewarticle/578464...

Table of Valid Genomic Biomarkers in the Context of Approved Drug ...
18 Aug 2009 ... FDA, U S Food and Drug Administration. Enter Search terms ... Your doctor will do a blood test to see if you have been infected with CCR5-tropic .... G6PD
Deficiency, G6PD deficiency and risk “Rasburicase administered to ...
http://www.fda.gov/Drugs/ScienceResearch/ResearchAreas/Pharm...

Pharmacogenomic Biomarkers of Susceptibility to Adverse Drug ...
Biomarkers of ADR Susceptibility in US FDA-approved Product Labels: What are the ... Rasburicase, G6PD deficiency, Fluorescent spot test; enzyme activity ...
http://www.medscape.com/viewarticle/586268_4...

Table 2 : Is personalized medicine finally arriving? : Nature ...
Testing required by FDA. Erbitux/colon cancer, Imclone, EGFR pharmDX/DAKO ... Elitek (rasburicase)/cancer, Sanofi-Aventis, G6PD deficiency/various ...
http://www.nature.com/nbt/journal/v26/n5/fig_tab/nbt0508-509...

Pharmacogenomic Biomarkers of Susceptibility to Adverse Drug ...
US FDA: Table of valid genomic biomarkers in the context of approved drug labels ... Rasburicase, G6PD deficiency, Fluorescent spot test; enzyme activity ...
http://www.medscape.com/viewarticle/586268_5...

ELITEK (rasburicase) kit [sanofi-aventis US LLC] - DailyMed: About ...
Download the FDA official PDF of this label. Search By Drug Name: ... It is recommended that patients at higher risk for G6PD deficiency (e.g., ... within 4
hours of sample collection (see PRECAUTIONS, Laboratory Test Interactions). ...
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=8374...

Drug Disposition in Organ Transplant Patients
about the cost effectiveness of pharmacogenetic testing in clinical practice. ... Information only. G6PD Deficiency. Rasburicase. Information only. NAT
Variants .... FDA ALERT [12/12/2007]: Dangerous or even fatal skin reactions ...
http://www.fda.gov/downloads/Drugs/ScienceResearch/ResearchA...

PDF - AIST: 産業技術総合研究所
G6PD 異常症患者への Rasburicase 投与は、重度の溶血反応を引き起こすことがあり、 ...... for Clinical Multiplex Test Systems. 7. 産業界及びFDAスタッフ向け ...
http://www.aist.go.jp/aist_j/aistinfo/report/entrust/iryouki...

Google Custom Search

Search
  


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.